References
- Edwards C Q, Griffen L M, Goldgar D, Drummond C, Skolnick M H, Kushner J P. Prevalence of hemochromatosis among 11 065 presumably healthy blood donors. N Engl J Med 1988; 318: 1355–1362
- Smith B N, Kantrowitz W, Grace N D, Greenberg M S, Patton T J, Ookubu R, et al. Prevalence of hereditary hemochromatosis in a Massachusetts corporation: is a celtic origin a risk factor?. Hepatology 1997; 25: 1439–1446
- Feder J N, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy D A, Basava A, et al. A novel MHC class 1-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996; 13: 399–408
- Parkkila S, Parkkila A K, Waheed A, Britton R S, Zhou X Y, Fleming T E, et al. Cell surface expression of HFE protein in epithelial cells, macrophages, and monocytes. Haematologica 2000; 85: 340–345
- Chitambar C R, Wereley J P. Iron transport in lymphoid cell line with the hemochromatosis C282Y mutation. Blood 2001; 97: 2734–2740
- Nelson R L, Davis F G, Persky V, Becker E. Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer 1995; 76: 875–879
- Lichtman S M, Attivissimo L, Goldman I S, Schuster M W, Buchbinder A. Secondary hemochromatosis as a long term complication of the treatment of hematologic malignancies. Am J Hematol 1999; 61: 262–264
- Hannuksela J, Savolainen E R, Koistinen P, Parkkila S. Prevalence of HFE genotypes C282Y and H63D in patients with hematologic disorders. Haematologica 2002; 87: 131–135
- Gimferrer E, Nomdedeu J, Gich I, Barcelò M J, Baiget M. Prevalence of hemochromatosis related HFE gene mutations in patients with acute myeloid leukemia. Leuk Res 1999; 23: 597–598
- Salvioni A, Mariani R, Oberkanins C, Moritz A, Mauri V, Pelucchi S, et al. Prevalence of C282Y and E158X mutation in an italian population of Northern European ancestry. Haematologica 2003; 88: 250–255
- Pietrapertosa A, Vitucci A, Campanale D, Palma A, Renni R, Delios G, et al. HFE gene mutation an Apulian population: allele frequencies. Eur J Epidemiol 2003; 18: 685–689
- Velati C, Marlianici E, Rigamonti D, Barillari G, Chiavilli F, Fugiani P, et al. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation. Hematol J 2003; 4: 436–430
- Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D AG, Gralnick H R, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 105: 620–625
- Ferrara F, Morabito F, Martino B, Specchia G, Liso V, Nobile F, et al. CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous All-trans-Retinoic acid and chemotherapy. J Clin Oncol 2000; 18: 1295–1300
- Sebastio L, Ferrara F, Vicari L, Di Noto R, Del Vecchio L, Pane F, et al. Simultaneous occurence of tetrasomy 21 and trisomy 8 in a patient with early blastic metamorphosis of chronic myeloproliferative disorder. Am J Hematol 1995; 50: 49–52
- Miller S A, Dykes D D, Polisky H F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215
- Barton C J, Bertoli F L, Acton T A. HFE C282Y and H63D in adults with malignancies in a community medical oncology practice. BMC Cancer 2004; 1: 4–6
- Kondrashova T V, Neriishi K, Ban S, Ivanova T I, Krikunova L I, Shentereva N I, et al. Frequency of hemochromatosis gene (HFE) mutations in Russian healthy women and patients with estrogen-dependent cancers. Biochim Biophys Acta 2005; 1762: 59–65
- Gunel-Ozcan A, Alyilmaz-Bekmez S, Nilufer Guler E, Guc D. HFE H63D mutation frequency shows an increase in Turkish women with breast cancer. BMC Cancer 2006; 6: 37
- Franchini M, Veneri D. Iron overload and hematologic malignancies. Hematol J 2004; 5: 381–383
- Dorak M T, Burnett A K, Worwood M. HFE gene mutations in susceptibility to childhood leukemia: HuGE review. Genet Med 2005; 7: 159–168
- Veneri D, Franchini M, Krampera M, De Matteis G, Solero P, Pizzolo G. Analysis of the HFE and TFR2 gene mutations in patients with acute leukemia. Leuk Res 2005; 6: 661–664
- Dorak M T, Burnett A K, Worwood M, Sproul A M, Gibson B E. The C282Y mutation of the HFE is another male-specific risk factor for childhood acute lymphoblastic leukemia. Blood 1999; 94: 694–700